 treatment psoriasis clinical mechanistic perspective unique immunomodulatory agent last years management severe psoriasis remarkable efficacy drug immunosuppressive properties appreciation role immune system induction maintenance psoriatic plaques lymphocytes evidence effect cyclosporine constitutive cell types skin future use cyclosporine treatment psoriasis cutaneous diseases dependent successful balance efficacy side-effect profile dose-related problems hypertension nephrotoxicity result toxicity cyclosporine successful topical preparation use cutaneous disease advent cyclosporine dermatologist new therapeutic strategem management psoriasis long-term safety interventional therapy